Lilburn, GA, United States of America

Vera A Semenova


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Vera A. Semenova

Introduction

Vera A. Semenova is a notable inventor based in Lilburn, GA, who has made significant contributions to the field of immunology through her innovative research and inventions. With a portfolio of four patents, her work focuses on identifying protective antigens and developing vaccines aimed at enhancing acquired immunity.

Latest Patents

Two of Vera A. Semenova's latest patents revolve around regions of protective antigens that represent epitopes recognized by antibodies in subjects who have obtained immunity to specific infections. These antigens are crucial as their recognition correlates with autoimmunity in individuals. The patents also detail vaccines that incorporate at least one of these epitopes, which, when administered, can provide improved acquired immunity to subjects.

Career Highlights

Vera's career is distinguished by her role at the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. Through her position, she has been able to drive her research initiatives forward, contributing to advancements in vaccine development and autoimmune disease understanding.

Collaborations

Throughout her career, Vera has collaborated with esteemed colleagues, including Conrad Padraig Quinn and Jan Pohl. These partnerships highlight the collaborative efforts within the research community to tackle complex health issues and innovate effective solutions for the public.

Conclusion

Vera A. Semenova's work epitomizes the dedication and innovation of contemporary inventors in the realm of health and immunology. Through her patents and collaborations, she continues to impact the field profoundly, paving the way for future advancements in vaccine technology and autoimmune research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…